Raymond James & Associates’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $58.9K | Hold |
|
|||||
|
2022
Q4 | $69K | Sell |
|
|||||
|
2022
Q3 | $49K | Sell |
|
|||||
|
2022
Q2 | $102K | Sell |
|
|||||
|
2022
Q1 | $323K | Sell |
|
|||||
|
2021
Q4 | $370K | Sell |
|
|||||
|
2021
Q3 | $641K | Buy |
|
|||||
|
2021
Q2 | $632K | Buy |
|
|||||
|
2021
Q1 | $511K | Buy |
|
|||||
|
2020
Q4 | $437K | Sell |
|
|||||
|
2020
Q3 | $807K | Sell |
|
|||||
|
2020
Q2 | $2.56M | Buy |
|
|||||
|
2020
Q1 | $1.19M | Sell |
|
|||||
|
2019
Q4 | $2.33M | Buy |
|
|||||
|
2019
Q3 | $1.22M | Buy |
|
|||||
|
2019
Q2 | $838K | Buy |
|
|||||
|
2019
Q1 | $713K | Buy |
|
|||||
|
2018
Q4 | $589K | Buy |
|
|||||
|
2018
Q3 | $984K | Buy |
|